Primer Kutanöz Müsinöz Karsinom
Özet
Primer kutanöz müsinöz karsinom, ekstraselüler müsin havuzları içinde yüzen epitelial hücre adaları ile karakterize, oldukça nadir görülen ve memenin müsinöz karsinomuna morfolojik benzerlik gösteren malign bir deri eki tümörüdür. Genellikle 60-70 yaş aralığındaki bireylerde, yüz, göz kapağı ve skalp yerleşimli, yavaş büyüyen tekil kistik nodüller şeklinde klinik görünüm sergiler. Histopatolojik olarak, neoplazmın büyük kısmını oluşturan müsinöz komponentin varlığına göre pür ve mikst tiplere ayrılır; histokimyasal boyamalarda daza dirençli PAS, Alcian mavisi ve musikarmen pozitifliği tipiktir. Ayırıcı tanıda en kritik parametre, tümörün metastatik değil primer kökenli olduğunu kanıtlayan in situ komponentin varlığıdır; zira lezyon immünohistokimyasal olarak CK7, ER, PR ve GATA-3 pozitifliği, CK20 negatifliği ile karakterize olup başta meme olmak üzere diğer organ metastazları ile tamamen aynı fenotipi paylaşabilir. Sınırlarının net seçilememesi nedeniyle %20 civarında lokal nüks eğilimi gösteren tümörde, Mohs cerrahisi nüks oranlarını belirgin şekilde düşürürken, meme tümörlerinin aksine histolojik alt tipler arasında prognoz farkı izlenmez ve uzak metastaz oldukça nadirdir.
Primary cutaneous mucinous carcinoma is an extremely rare malignant adnexal tumor characterized by epithelial cell islands floating within extracellular mucin pools, showing morphological similarities to mucinous carcinoma of the breast. It typically presents in patients aged 60-70 as a slow-growing, solitary cystic nodule predominantly located on the face, eyelids, and scalp. Histopathologically, it is classified into pure and mixed types based on the mucinous component; histochemical staining characteristically demonstrates diastase-resistant PAS, Alcian blue, and mucicarmine positivity. The presence of an in situ component is the most critical parameter in differential diagnosis to confirm its primary cutaneous origin, as the tumor shares identical immunophenotypes—such as CK7, ER, PR, and GATA-3 positivity with CK20 negativity—with metastatic carcinomas, particularly from the breast. Due to ill-defined margins, it exhibits a local recurrence rate of approximately 20%, which is significantly reduced by Mohs micrographic surgery, though unlike breast tumors, histological subtypes do not influence clinical prognosis, and distant metastasis remains exceptionally rare.
Referanslar
Lennox B, Pearse AG, Richards HG. Mucin-secreting tumours of the skin with special reference to the so-called mixed-salivary tumour of the skin and its relation to hidradenoma. J Pathol Bacteriol 1952; 64: 865-880.
Headington JT. Primary mucinous carcinoma of skin: histochemistry and electron microscopy. Cancer 1977; 39: 1055-1063.
Kazakov DV, Suster S, LeBoit PE et al. Mucinous carcinoma of the skin, primary, and secondary: a clinicopathologic study of 63 cases with emphasis on the morphologic spectrum of primary cutaneous forms: homologies with mucinous lesions in the breast. Am J Surg Pathol 2005; 29: 764-782.
Rahilly MA, Beattie GJ, Lessells AM. Mucinous eccrine carcinoma of the vulva with neuroendocrine differentiation. Histopathology 1995; 27: 82-86.
Robinson M, Kelly J, Biberdorf D, McAuley I. Primary cutaneous mucinous carcinoma of the penis. Can Urol Assoc J 2014; 8: E89-91.
Abiola OO, Ano-Edward GH, Oluwumi OA, Lasisi ME. Primary cutaneous mucinous carcinoma of the scrotum: A rare tumor at a rare site - A case report and review of literature. Urol Ann 2020; 12: 83-86.
Chung-Park M, Zheng Liu C, Giampoli EJ et al. Mucinous adenocarcinoma of ectopic breast tissue of the vulva. Arch Pathol Lab Med 2002; 126: 1216-1218.
Bertagnoli R, Cook DL, Goldman GD. Bilateral primary mucinous carcinoma of the eyelid treated with Mohs surgery. Dermatol Surg 1999; 25: 566-568.
Papalas JA, Proia AD. Primary mucinous carcinoma of the eyelid: a clinicopathologic and immunohistochemical study of 4 cases and an update on recurrence rates. Arch Ophthalmol 2010; 128: 1160-1165.
Snow SN, Reizner GT. Mucinous eccrine carcinoma of the eyelid. Cancer 1992; 70: 2099-2104.
Wako M, Nishimaki K, Kawamura N et al. Mucinous carcinoma of the skin with apocrine-type differentiation: immunohistochemical studies. Am J Dermatopathol 2003; 25: 66-70.
Kazakov DV, Michal M, Kacerovska D, McKee P. Cutaneous Adnexal Tumors. Wolters Kluwer Health | Lippincott Williams & Wilkins,2012.
Calonje E, Brenn T, Lazar A, Billings S. McKee’s Pathology of the Skin with Clinical Correlations.2020.
Elder D, Massi D, Scolyer R, Willemze R. WHO Classification of Skin Tumours 2018
Abdulkader M, Kuhar M, Hattab E, Linos K. GATA3 Positivity in Endocrine Mucin-Producing Sweat Gland Carcinoma and Invasive Mucinous Carcinoma of the Eyelid: Report of 2 Cases. Am J Dermatopathol 2016; 38: 789-791.
Kwatra KS, Prabhakar BR, Jain S. Oestrogen and progesterone receptors in primary mucinous carcinoma of skin. Australas J Dermatol 2005; 46: 246-249.
Breiting L, Dahlstrom K, Christensen L et al. Primary mucinous carcinoma of the skin. Am J Dermatopathol 2007; 29: 595-596.
Jih MH, Friedman PM, Kimyai-Asadi A, Goldberg LH. A rare case of fatal primary cutaneous mucinous carcinoma of the scalp with multiple in-transit and pulmonary metastases. J Am Acad Dermatol 2005; 52: S76-80.
Rasmussen BB. Human mucinous breast carcinomas and their lymph node metastases. A histological review of 247 cases. Pathol Res Pract 1985; 180: 377-382.
Kamalpour L, Brindise RT, Nodzenski M et al. Primary cutaneous mucinous carcinoma: a systematic review and meta-analysis of outcomes after surgery. JAMA Dermatol 2014; 150: 380-384.
Paradela S, Castineiras I, Cuevas J et al. Mucinous carcinoma of the skin: evaluation of lymphatic invasion with D2-40. Am J Dermatopathol 2008; 30: 504-508.
